Published in J Neural Transm (Vienna) on September 18, 2010
Lifelong brain health is a lifelong challenge: from evolutionary principles to empirical evidence. Ageing Res Rev (2015) 0.87
Positive affect and age as predictors of exercise compliance. PeerJ (2014) 0.83
Effects of using the nintendo wii fit plus platform in the sensorimotor training of gait disorders in Parkinson's disease. Neurol Int (2014) 0.80
Restoration of MPTP-induced deficits by exercise and Milmed(®) co-treatment. PeerJ (2014) 0.75
Effects of Moderate Aerobic Exercise on Cognitive Abilities and Redox State Biomarkers in Older Adults. Oxid Med Cell Longev (2016) 0.75
FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF. J Biol Chem (2016) 0.75
Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci (2001) 11.40
Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci (2002) 7.10
Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science (1996) 5.57
Exercise and brain neurotrophins. Nature (1995) 4.06
The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord (2008) 3.30
Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res (1996) 3.18
Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J Neurophysiol (2002) 2.96
Motor training induces experience-specific patterns of plasticity across motor cortex and spinal cord. J Appl Physiol (1985) (2006) 2.14
BDNF function and intracellular signaling in neurons. Histol Histopathol (2010) 1.99
Motor training effects on recovery of function after striatal lesions and striatal grafts. Exp Neurol (2003) 1.85
Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res (2004) 1.84
Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience (2003) 1.83
Eps8 regulates axonal filopodia in hippocampal neurons in response to brain-derived neurotrophic factor (BDNF). PLoS Biol (2009) 1.78
Behavioral tests for preclinical intervention assessment. NeuroRx (2006) 1.75
Differential activity-dependent secretion of brain-derived neurotrophic factor from axon and dendrite. J Neurosci (2009) 1.74
Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci (2007) 1.73
Antidepressant actions of the exercise-regulated gene VGF. Nat Med (2007) 1.69
Endurance training enhances BDNF release from the human brain. Am J Physiol Regul Integr Comp Physiol (2009) 1.67
Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci (2001) 1.66
Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem (2003) 1.53
Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth. Nat Neurosci (2000) 1.51
Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res (1998) 1.42
Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci (2002) 1.40
BDNF induction with mild exercise in the rat hippocampus. Biochem Biophys Res Commun (2007) 1.39
Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis. Hippocampus (2010) 1.37
Exercise induces BDNF and synapsin I to specific hippocampal subfields. J Neurosci Res (2004) 1.28
Exercise increases BDNF levels in the striatum and decreases depressive-like behavior in chronically stressed rats. Metab Brain Dis (2009) 1.24
Can the brain be protected through exercise? Lessons from an animal model of parkinsonism. Exp Neurol (2003) 1.22
The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Semin Speech Lang (2006) 1.16
Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol (1999) 1.13
Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats. Neuroscience (2008) 1.13
Actions of neurotrophic factors and their signaling pathways in neuronal survival and axonal regeneration. Mol Neurobiol (2006) 1.10
Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection. Neuroscience (2006) 1.09
Hippocampal brain-derived neurotrophic factor but not neurotrophin-3 increases more in mice selected for increased voluntary wheel running. Neuroscience (2003) 1.08
Selection for aerobic capacity affects corticosterone, monoamines and wheel-running activity. Physiol Behav (2008) 1.05
The effects of loading and unloading treadmill walking on balance, gait, fall risk, and daily function in Parkinsonism. NeuroRehabilitation (2005) 1.05
Regulation of neonatal development of retinal ganglion cell dendrites by neurotrophin-3 overexpression. J Comp Neurol (2009) 1.04
Pharmacomimetics of exercise: novel approaches for hippocampally-targeted neuroprotective agents. Curr Med Chem (2009) 1.02
Exercise-induced normalization of decreased BDNF serum concentration in elderly women with remitted major depression. Int J Neuropsychopharmacol (2010) 1.02
Neonatal exposure to decabrominated diphenyl ether (PBDE 209) results in changes in BDNF, CaMKII and GAP-43, biochemical substrates of neuronal survival, growth, and synaptogenesis. Neurotoxicology (2007) 1.01
The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur J Pharmacol (1986) 1.01
Maternal separation of rat pups increases the risk of developing depressive-like behavior after subsequent chronic stress by altering corticosterone and neurotrophin levels in the hippocampus. Neurosci Res (2008) 1.00
Immediate effects of speed-dependent treadmill training on gait parameters in early Parkinson's disease. Arch Phys Med Rehabil (2003) 0.99
Exercise-induced motor improvement after complete spinal cord transection and its relation to expression of brain-derived neurotrophic factor and presynaptic markers. BMC Neurosci (2009) 0.98
Gating of BDNF-induced synaptic potentiation by cAMP. Science (1999) 0.98
Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y. Brain Res (1999) 0.96
Physical exercise alleviates debilities of normal aging and Alzheimer's disease. Acta Neurol Scand (2010) 0.94
The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci (2001) 0.94
Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. J Alzheimers Dis (2009) 0.94
Exercise therapy for Parkinson's disease. Arch Phys Med Rehabil (1986) 0.93
TrkB-mediated activation of geranylgeranyltransferase I promotes dendritic morphogenesis. Proc Natl Acad Sci U S A (2008) 0.93
Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease. Behav Brain Res (2005) 0.92
MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci (1985) 0.89
Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease. Brain Res (1990) 0.88
Influence of noradrenaline denervation on MPTP-induced deficits in mice. J Neural Transm (Vienna) (2005) 0.88
Brain-derived neurotrophic factor controls activity-dependent maturation of CA1 synapses by downregulating tonic activation of presynaptic kainate receptors. J Neurosci (2009) 0.87
Exercise improves efficacy of levodopa in patients with Parkinson's disease. Mov Disord (2007) 0.86
Dendritic branching of olfactory bulb mitral and tufted cells: regulation by TrkB. PLoS One (2009) 0.86
Influence of physical exercise on neuroimmunological functioning and health: aging and stress. Neurotox Res (2010) 0.85
Effect of exercise on dopamine neuron survival in prenatally stressed rats. Metab Brain Dis (2009) 0.84
Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res (2010) 0.84
Prenatal exposure to methylphenidate hydrochloride decreases anxiety and increases exploration in mice. Pharmacol Biochem Behav (2004) 0.84
Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Mol Chem Neuropathol (1989) 0.84
Exercise alleviates Parkinsonism: clinical and laboratory evidence. Acta Neurol Scand (2011) 0.84
MPTP-induced behavioural and biochemical deficits: a parametric analysis. J Neural Transm Park Dis Dement Sect (1994) 0.83
Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits. Parkinsonism Relat Disord (2001) 0.83
MPTP-induced hypoactivity in mice: reversal by L-dopa. Pharmacol Toxicol (1990) 0.82
A chronic mouse model of Parkinson's disease has a reduced gait pattern certainty. Neurosci Lett (2007) 0.82
An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice. J Neural Transm (Vienna) (2003) 0.81
Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat. Psychopharmacology (Berl) (1986) 0.81
Monoamine oxidase A activity and norepinephrine level in hippocampus determine hyperwheel running in SPORTS rats. Neuropsychopharmacology (2006) 0.81
Exercise treatment for bipolar disorder: potential mechanisms of action mediated through increased neurogenesis and decreased allostatic load. Psychother Psychosom (2009) 0.80
Effects of unpredictable chronic stress on behavior and brain-derived neurotrophic factor expression in CA3 subfield and dentate gyrus of the hippocampus in different aged rats. Chin Med J (Engl) (2009) 0.80
The protein dendrite arborization and synapse maturation 1 (Dasm-1) is dispensable for dendrite arborization. Mol Cell Biol (2008) 0.80
The influence of environment and experience on neural grafts. Nat Rev Neurosci (2001) 0.79
Development of a mild prenatal stress rat model to study long term effects on neural function and survival. Metab Brain Dis (2007) 0.79
Physical exercise attenuates MPTP-induced deficits in mice. Neurotox Res (2010) 0.79
The benefit of a home exercise regimen for ambulatory Parkinson's disease patients. J Neurosci Nurs (1989) 0.78
Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists. J Med Chem (1995) 0.77
Morphological and cellular changes within embryonic striatal grafts associated with enriched environment and involuntary exercise. Eur J Neurosci (2006) 0.77
Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor. Neurochem Res (2007) 0.77
(S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat. Eur J Pharmacol (1991) 0.77
Establishing physical objectives in the rehabilitation of patients with Parkinson's disease; gymnasium activities. Phys Ther Rev (1956) 0.76
Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists. J Neural Transm (Vienna) (1999) 0.76
Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration. Behav Brain Res (2003) 0.76
Postnatal iron overload destroys NA-DA functional interactions. J Neural Transm (Vienna) (2006) 0.75
Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav Brain Res (2004) 1.95
Anxiety, affect, self-esteem, and stress: mediation and moderation effects on depression. PLoS One (2013) 1.25
The affective profiles in the USA: happiness, depression, life satisfaction, and happiness-increasing strategies. PeerJ (2013) 1.22
Moral stress, moral climate and moral sensitivity among psychiatric professionals. Nurs Ethics (2010) 1.11
Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotox Res (2004) 1.08
Temperament, character, and adolescents' depressive symptoms: focusing on affect. Depress Res Treat (2012) 1.02
The neuropsychology of patients with clinically diagnosed idiopathic normal pressure hydrocephalus. Neurosurgery (2007) 0.97
International note: temperament and character's relationship to subjective well-being in Salvadorian adolescents and young adults. J Adolesc (2013) 0.96
Iranian and Swedish adolescents: differences in personality traits and well-being. PeerJ (2013) 0.96
Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res (2006) 0.95
Effects of physical exercise on depressive symptoms and biomarkers in depression. CNS Neurol Disord Drug Targets (2014) 0.94
Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr Res (2007) 0.94
Predicting performance in ski and swim championships: effectiveness of mood, perceived exertion, and dispositional optimism. Percept Mot Skills (2002) 0.92
Neuropsychological effects of shunt treatment in idiopathic normal pressure hydrocephalus. Neurosurgery (2008) 0.91
High second-language proficiency protects against the effects of reverberation on listening comprehension. Scand J Psychol (2014) 0.90
Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders. Neurotox Res (2007) 0.86
Swedish attitudes towards persons with mental illness. Nord J Psychiatry (2011) 0.85
Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility. Pharmacol Biochem Behav (2008) 0.85
Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent mechanisms. Behav Brain Res (2006) 0.83
Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise. Neurotox Res (2008) 0.82
Antagonism of the nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent inhibition in taste aversion conditioning. Behav Brain Res (2005) 0.81
Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine. Neurotox Res (2003) 0.81
Phencyclidine affects memory in a nitric oxide-dependent manner: working and reference memory. Behav Brain Res (2006) 0.81
Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry. Neurotox Res (2007) 0.80
Influence of moderate, daily physical activity on body composition and blood lipid profile in Swedish adults. J Phys Act Health (2011) 0.79
Comorbidity of substance abuse with other psychiatric disorders. Neurotox Res (2007) 0.79
Physical self-esteem, a five year follow-up study on Swedish adolescents. Int J Adolesc Med Health (2010) 0.78
Moral distress and its interconnection with moral sensitivity and moral resilience: viewed from the philosophy of Viktor E. Frankl. J Bioeth Inq (2013) 0.78
The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and conditioning. Behav Brain Res (2005) 0.78
Cognition and global assessment of functioning in male and female outpatients with schizophrenia spectrum disorders. J Nerv Ment Dis (2011) 0.77
Miss B Pursues Death and Miss P Life in the Light of V. E. Frankl's Existential Analysis/Logotherapy. Omega (Westport) (2015) 0.77
Neurodevelopmental liabilities in schizophrenia and affective disorders. Neurotox Res (2003) 0.76
Gene-environment interplay in neurogenesis and neurodegeneration. Neurotox Res (2004) 0.76
Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration. Behav Brain Res (2003) 0.76
Adolescents' fire-setting awareness under boredom: relation to personality variables. Psychol Rep (2004) 0.75
Gene-environment interplay in schizopsychotic disorders. Neurotox Res (2004) 0.75
Verbal learning in schizopsychotic outpatients and healthy volunteers as a function of cognitive performance levels. Arch Clin Neuropsychol (2007) 0.75
Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice. Neurotox Res (2006) 0.75
Experience of quality of life and attitude to care and treatment in patients with schizophrenia: Role of cross-sectional remission. Int J Psychiatry Clin Pract (2008) 0.75
Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths. Neurotox Res (2008) 0.75
Comorbidity implications in brain disease: neuronal substrates of symptom profiles. Neurotox Res (2007) 0.75